These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 20390230

  • 1. Thrombophilic risk factors and peripheral arterial disease severity.
    Sartori M, Favaretto E, Legnani C, Cini M, Conti E, Amato A, Palareti G.
    Thromb Haemost; 2010 Jul; 104(1):71-7. PubMed ID: 20390230
    [Abstract] [Full Text] [Related]

  • 2. Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
    Sartori M, Conti E, Favaretto E, Frascaro M, Legnani C, Palareti G.
    Eur J Vasc Endovasc Surg; 2011 Dec; 42(6):817-23. PubMed ID: 21982452
    [Abstract] [Full Text] [Related]

  • 3. G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease.
    Sartori M, Favaretto E, Legnani C, Cini M, Conti E, Pili C, Palareti G.
    Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):113-7. PubMed ID: 19356951
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
    French JK, Van de Water NS, Sutton TM, Lund M, Gao W, McDowell J, Liu-Stratton Y, Pohorence J, Szymanski D, Goldschmidt-Clermont P, White HD, Browett PJ, Cooke G.
    Am Heart J; 2003 Jan; 145(1):118-24. PubMed ID: 12514663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
    Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L, FITENAT Study Group.
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
    [Abstract] [Full Text] [Related]

  • 10. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
    Heylen E, Miljic P, Willemse J, Djordjevic V, Radojkovic D, Colovic M, Elezovic I, Hendriks D.
    Thromb Res; 2009 Sep; 124(4):427-32. PubMed ID: 19195685
    [Abstract] [Full Text] [Related]

  • 11. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, Todoli J, Simó M, Corella D, Ricart JM.
    Clin Hemorheol Microcirc; 2008 Sep; 40(2):79-87. PubMed ID: 19029633
    [Abstract] [Full Text] [Related]

  • 12. Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis.
    Vazquez F, Rodger M, Carrier M, Le Gal G, Reny JL, Sofi F, Mueller T, Nagpal S, Jetty P, Gandara E.
    Eur J Vasc Endovasc Surg; 2015 Aug; 50(2):232-40. PubMed ID: 26092622
    [Abstract] [Full Text] [Related]

  • 13. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
    Weger M, Renner W, Steinbrugger I, Cichocki L, Temmel W, Stanger O, El-Shabrawi Y, Lechner H, Schmut O, Haas A.
    Ophthalmology; 2005 Nov; 112(11):1910-5. PubMed ID: 16157382
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage.
    Glueck CJ, Pranikoff J, Aregawi D, Haque M, Zhu B, Tracy T, Wang P.
    Metabolism; 2005 Oct; 54(10):1345-9. PubMed ID: 16154434
    [Abstract] [Full Text] [Related]

  • 16. Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: a cross-sectional study of 275 hyperlipidemic women.
    Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Lang JE.
    Metabolism; 2001 Mar; 50(3):360-5. PubMed ID: 11230792
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
    Okumus G, Kiyan E, Arseven O, Tabak L, Diz-Kucukkaya R, Unlucerci Y, Abaci N, Unaltuna NE, Issever H.
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
    [Abstract] [Full Text] [Related]

  • 20. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
    Hendler MF, Meschengieser SS, Blanco AN, Alberto MF, Salviú MJ, Gennari L, Lazzari MA.
    Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.